Abstract:Objectives This study is designated to investigate the mechanism involved in the mechanical stress induced-cardiomyocyte autophagy. Methods We investigated the role of angiotensin II type 1 (AT1)receptor and mitogen-activated protein kinase (MAPK) in mechanical stress-induced autophagic response in cardiomyocytes. LC3b, a marker of autophagy, was detected by western blot analysis. In addition, mice were subjected to transverse aortic constriction (TAC) for 4 weeks to test the effect of autophagy. Results After mechanical stretch stimulation (48 h), neonatal cardiomyocytes expressed hypertrophic responses and remarkable up-regulation of LC3b. While losartan, an AT1 receptor antagonist, not only attenuated cardiac hypertrophy but also abrogated up-regulation of LC3b induced by mechanical stresses. And treatment with PD123319, the AT2 receptor antagonist, did not reverse mechanical stress-induced autophagy. We also investigated the change of activity of MAPK pathway in the autophagy induced by mechanical stress. We found that the phosphorylation of ERK, JNK and p38 were significantly increased after stimulation compared with Control group. The increase of LC3b was significantly blocked by SB 203580, a p38 MAPK inhibitor. However, treatment with PD98059, an ERK inhibitor, or SP600125, a JNK inhibitor, did not abrogate the mechanical stress-induced autophagy. AT1 mediated autophagic and hypertrophic responses were also assessed in vivo. The expression of LC3b in left ventricular cardiomyocyte increased significantly in TAC-operated mice compared with that in sham-operated mice. And losartan significantly inhibited the up-regulation of LC3b induced by chronic pressure overload. Moreover, losartan also ameliorated cardiac remodelling and dysfunction induced by TAC after 4 weeks. Conclusions The results indicate that autophagy in cardiomyocytes induced by mechanical stress is AT1 receptor-dependent, and is through p38 MAPK signal pathway.

Autophagy and Pressure Overload-Induced Cardiac Hypertrophy.

Regulatory role of autophagy in development of pulmonary artery hypertension

Research progress of autophagy in heart failure

Redox Regulation of Autophagy in Dilated and Hypertrophic Cardiomyopathy

Regulation of Autophagy in Obesity-Induced Cardiac Dysfunction

Autophagy And Cardiac Diseases: Therapeutic Potential Of Natural Products

Autophagy Controls Nrf2-Mediated Dichotomy in Pressure Overloaded Hearts

Research Progress on the Interaction Between Autophagy and Energy Homeostasis in Cardiac Remodeling

ANGIOTENSIN II TYPE 1 RECEPTOR MEDIATED CARDIOMYOCYTE AUTOPHAGY INDUCED BY MECHANICAL STRESS THROUGH P38 MAPK

The role of autophagy in cardiovascular disease: Cross-interference of signaling pathways and underlying therapeutic targets

High-density lipoprotein inhibits mechanical stress-induced cardiomyocyte autophagy and cardiac hypertrophy through angiotensin II type 1 receptor-mediated PI3K/Akt pathway.

Innate Immune Cells in Pressure Overload-Induced Cardiac Hypertrophy and Remodeling

Mitochondria in Pathological Cardiac Hypertrophy Research and Therapy

Ang II Promotes Cardiac Autophagy and Hypertrophy via Orai1/STIM1

Oxidative Stress Impairs Myocyte Autophagy, Resulting in Myocyte Hypertrophy

Autophagy in cardiovascular health and disease

Berberine improves pressure overload-induced cardiac hypertrophy and dysfunction through enhanced autophagy.

Role of autophagy in myocardial remodeling after myocardial infarction

Hyperoside Protects Against Pressure Overload-Induced Cardiac Remodeling via the AKT Signaling Pathway

Autophagy as an emerging target in cardiorenal metabolic disease: From pathophysiology to management

Refining the Role of Autophagy in Hypertrophic Cardiomyopathy